Searchable abstracts of presentations at key conferences in endocrinology

ea0098c48 | Clinical – Surgery/Applied Pathology | NANETS2023

Predictors of low-to-high grade progression in pancreatic neuroendocrine tumors

Wang Stephanie J. , Moon Farhana , Joseph Nancy , Nakakura Eric , Khuong Le Bryan , Zhang Li , Bergsland Emily

Background: Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous, with grade (G) defined by Ki67 proliferation index (<3% G1, 3-20% G2, >20% G3) or mitotic rate. The G3 NEN subgroup is further divided into well differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NEC). Grade progression can occur over time, with low-to-high grade progression (L-to-H; G1/2 to G3) the most clinically relevant form. It is associated w...

ea0098p1 | Population Science | NANETS2023

Rising incidence of bronchopulmonary neuroendocrine tumors

Paciorek Alan , Moon Farhana , Khuong Le Bryan , Zhang1, Li , Steiding Paige , Bergsland Emily , Mulvey Claire

Background: The epidemiology of typical (TC) and atypical carcinoid (AC) bronchopulmonary neuroendocrine tumors (pulmNETs) is not well understood. We aim to describe the incidence of pulmNETs and differences by sex and race and ethnicity (R&E) in the diverse state of California.Methods: All patients with malignant pulmNETs diagnosed from 1992-2019 in the population-based California Cancer Registry were identified by histology (ICD-O-3 code 8240 for T...

ea0099p247 | Calcium and Bone | ECE2024

More potent antiresorptive effect of denosumab versus zoledronate in osteoporotic postmenopausal women with primary hyperparathyroidism

Kozamernik Katarina Mlekus , Ležaić Luka , Hočevar Marko , Kocjan Tomaž

Introduction: Primary hyperparathyroidism (PHPT) is a state of increased bone turnover that can result in secondary osteoporosis. Antiresorptive treatment can be used to preserve bone mineral density (BMD). We compared the impact of zoledronate and denosumab on bone-related biochemical parameters.Methods: We analyzed interim data from our ongoing randomized trial on osteoporotic postmenopausal women with PHPT who are being treated with either zoledronate...

ea0099p455 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Effect of prior GLP-1 RA treatment on clinical outcomes in patients with type 2 diabetes initiating treatment with tirzepatide

Suliman Mohammed , Buckley Adam , Allum Matthew , Lessan Nader , Mohammed Nagi , le Roux Carel , Suliman Sara

Background: Tirzepatide is a GLP-1/GIP co-agonist treatment for type 2 diabetes. Participants in the SURPASS trials were GLP-1RA naïve, but in clinical practice many patients are switched from other GLP-1RAs.Aims: To explore effects of prior GLP-1RA treatment on tirzepatide therapy outcomes.Methods: Review of clinical data from an outpatient Diabetes centre. Adults with 6 months follow-up post tirzepatide initiation were inclu...

ea0070aep542 | Environmental Endocrinology | ECE2020

A monitoring project to study nationwide trends of endometriosis incidence for environmental purposes inFrance: First step results

Rigou Annabel , Chesneau Julie , Canis Michel , Daraï Emile , Fauconnier Arnaud , Balestier Anita , Kvaskoff Marina , Zacharopoulou Chrysoula , Peyronnet Alexia , Le Barbier Mélina , Le Moal Joëlle

Introduction: Endometriosis is a complex reproductive disease without clear etiology, thought to be on the increase, and possibly related to endocrine disruptor (EDs) exposure such as PCBs, dioxins, phthalates, or pesticides. It is part of a national project on reproductive health indicators related to EDs in France. We aimed to build a nationwide indicator of endometriosis incidence based on routinely collected data, usable to study temporal and spatial trends for environment...

ea0081oc10.1 | Oral Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Single-cell molecular and functional mapping of POMC neurons in obesity: a multi-modal approach

Leon Stephane , Simon Vincent , Lee Thomas H , Clark Samantha , Dupuy Nathalie , Le Feuvre Yves , Fioramonti Xavier , Cota Daniela , Quarta Carmelo

The brain plays a crucial role in maintaining the body’s energy needs, a process involving the activity of a group of hypothalamic neurons that express the neuropeptidergic marker pro-opiomelanocortin (POMC). POMC neuronal dysfunction can cause obesity and its associated metabolic sequelae. However, this population of neurons is highly diverse at a molecular and functional level, and whether or not such heterogeneity is implicated in disease establishment or progression h...

ea0090p536 | Late-Breaking | ECE2023

Role of insulin therapy in weight gain: lessons from islet transplantation in type1 diabetes

Romain Bulois , Jannin Arnaud , Defrance Frederique , Mapihan Kristell Le , Mikael Chetboun , Julie Kerr-Conte , Francois Pattou , Vantyghem Marie-Christine

Background: Weight gain in type 1 diabetes (T1D) patients has become a clinical problem due to less strict diets and more stringent glycemic targets. Thus, the number of overweight T1D in the USA increased from 3.4% in 1988 to 22.7% in 2007. Hyperinsulinism is involved in the genesis of obesity but in T1D, the impact of insulin therapy in weight gain is not established. Islet transplantation, now reimbursed in France, makes it possible to interrupt insulin. The aim of this wor...

ea0091p16 | Poster Presentations | SFEEU2023

Oncocytic parathyroid adenoma presenting with refractory hypercalcaemia and multiple incidental Brown tumours

Azman Nur , Munisamy Narmadha , Le Carpentier Dana , Syed Maria , Spraggs Paul , Li Voon Chong Jimmy , Lambert Kimberley , Parsad Meenakshi

Case History: A 61-year-old Caucasian female from Ukraine presented with severe hypercalcaemia following routine blood tests performed by the GP. She reported symptoms of back pain and joint pains. She had renal stones 10 years prior. No history of thiazide or lithium use. No red flags; no change in appetite or weight loss. There was no familial history of Multiple Endocrine Neoplasia (MEN). Examination of her neck, cardiorespiratory, abdomen and breasts were normal. <p cl...

ea0063p106 | Calcium and Bone 1 | ECE2019

Case Report of a large family with hyperparathyroidism- jaw tumor syndrome (HPT-JT) and a deletion of the third exon of CDC73

Le Collen Lauriane , Barraud Sara , Francoise Odou Marie , Spodenkiewicz Marta , Braconnier Antoine , Zalzali Mohamad , Poirsier Celine , Delemer Brigitte

Heterozygote mutations of the gene CDC73 are responsible for 3 types of parathyroid diseases: familial hyperparathyroidism, parathyroid carcinoma, hyperparathyroidism-jaw tumor syndrome (and uterine or kidney lesions). The goal of our study was to describe the phenotype associated with the deletion of the 3rd exon of CDC73 found in a large family.Patients: We have medical records for 25 patients of a large family composed of 44 individu...